Cargando…

Prophylaxis of Cervical Cancer and Related Cervical Disease: A Review of the Cost-Effectiveness of Vaccination Against Oncogenic HPV Types

BACKGROUND: Vaccines have demonstrated cost-effectiveness in managed care through the prevention of disease. As new vaccines for previously untargeted conditions are developed, pharmacoeconomic modeling is becoming even more critical for the quantification of value in the health care industry. Two r...

Descripción completa

Detalles Bibliográficos
Autor principal:	Armstrong, Edward P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437588/ https://www.ncbi.nlm.nih.gov/pubmed/20331326 http://dx.doi.org/10.18553/jmcp.2010.16.3.217

Ejemplares similares

Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression
por: Liu, Hang, et al.
Publicado: (2022)

Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer
por: Faridi, Rabia, et al.
Publicado: (2011)

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
por: Hampson, Ian N.
Publicado: (2022)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

Cervical cancer in India and HPV vaccination
por: Kaarthigeyan, K.
Publicado: (2012)

Cervical Cancer HPV Vaccination and Bhutan
por: Hingmire, Sachin, et al.
Publicado: (2023)

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines
por: Cuschieri, K, et al.
Publicado: (2010)

SINGLE HPV VACCINE DOSE MAY BE EFFECTIVE AGAINST CERVICAL CANCER
Publicado: (2020)

Designing of multi-epitope chimeric vaccine using immunoinformatic platform by targeting oncogenic strain HPV 16 and 18 against cervical cancer
por: Kumar, Anoop, et al.
Publicado: (2022)

Diagnostic Management of Oncogenic HPV Cervical Infections: The Field Experience in Wuxi, China
por: Liu, Yang, et al.
Publicado: (2022)

A Review on the Use of the HPV Vaccine in the Prevention of Cervical Cancer
por: Pathak, Pranav, et al.
Publicado: (2022)

Therapeutic Vaccination for HPV Induced Cervical Cancers
por: Brinkman, Joeli A., et al.
Publicado: (2007)

Does HPV vaccination prevent cervical cancer?
por: Miller, Anthony B.
Publicado: (2013)

Comment on “Will HPV vaccination prevent cervical cancer”
por: Zhang, Shaokai, et al.
Publicado: (2020)

Cervical Cancer Screening and HPV Vaccination in Nepal
por: Baral, Gehanath, et al.
Publicado: (2023)

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
por: Naber, Steffie K., et al.
Publicado: (2016)

Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia
por: Sabol, Ivan, et al.
Publicado: (2017)

HPV-Related Cervical Cancer and Extracellular Vesicles
por: Kaczmarek, Magdalena, et al.
Publicado: (2022)

Monoclonal antibodies in cervical malignancy-related HPV
por: Aghbash, Parisa Shiri, et al.
Publicado: (2022)

Proposal for cervical cancer screening in the era of HPV vaccination
por: Ouh, Yung-Taek, et al.
Publicado: (2018)

Erratum: Cervical Cancer Screening and HPV Vaccination in Nepal
por: Baral, Gehanath, et al.
Publicado: (2023)

Current and future direction in treatment of HPV-related cervical disease
por: Khairkhah, Niloofar, et al.
Publicado: (2022)

Impact of HPV vaccination on HPV infection and cervical related disease burden in real-world settings (HPV-RWS): protocol of a prospective cohort
por: Liu, Zhike, et al.
Publicado: (2022)

hnRNP E1 Regulates HPV16 Oncogene Expression and Inhibits Cervical Cancerization
por: Song, Li, et al.
Publicado: (2022)

Kosovo women’s knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer
por: Raçi, Pranvera Zejnullahu, et al.
Publicado: (2021)

High prevalence of HPV 18 and multiple infections with oncogenic HPV genotypes in women at risk of cervical cancer examined in Manaus, Brazil
por: Fantin, C., et al.
Publicado: (2023)

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical
por: Mittendorf, Thomas, et al.
Publicado: (2007)

HPV types and cofactors causing cervical cancer in Peru
por: Santos, C, et al.
Publicado: (2001)

Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis
por: Lu, Beibei, et al.
Publicado: (2011)

Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign
por: Vu, Lan TH, et al.
Publicado: (2013)

Awareness and Knowledge of HPV, HPV Vaccination, and Cervical Cancer among an Indigenous Caribbean Community
por: Warner, Zachary Claude, et al.
Publicado: (2022)

Risk of HPV-related extra-cervical cancers in women treated for cervical intraepithelial neoplasia
por: Preti, Mario, et al.
Publicado: (2020)

HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia
por: Bierkens, Mariska, et al.
Publicado: (2012)

Anti-tumor effects of genetic vaccines against HPV major oncogenes
por: Cordeiro, Marcelo Nazário, et al.
Publicado: (2014)

Systematic review of the cost-effectiveness of the vaccination against HPV in Brazil
por: Fonseca, Allex Jardim, et al.
Publicado: (2014)

Tristetraprolin: a weapon against HPV-induced cervical cancer?
por: Gallouzi, Imed-Eddine, et al.
Publicado: (2009)

The involvement of HPV in cervical oncogenesis
por: Mitran, Mihai, et al.
Publicado: (2013)

Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women
por: Shiko, Yuki, et al.
Publicado: (2020)

One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer
Publicado: (2022)

HPV Vaccination: Predicting Its Effect on Cervical Cancer Rates
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_lbpem0i1gu4f7o68e0o4rprkr3